Cholera Vaccines Oral Live Market Report

Global Cholera Vaccines Oral Live Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 06, 2022
  • PAGES：215
  • REPORT CODE：GMM798365
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Cholera Vaccines Oral Live market report explains the definition, types, applications, major countries, and major players of the Cholera Vaccines Oral Live market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Shantha Biotechnics Limited

    • Valneva

    • Celldex Therapeutics

    • Merck

    • Ceva Asia

    • PaxVax

    By Type:

    • Dukoral

    • Shanchol

    • Vaxchora

    • Others

    By End-User:

    • Hospital

    • Scientific Research

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Cholera Vaccines Oral Live Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Cholera Vaccines Oral Live Outlook to 2028- Original Forecasts

    • 2.2 Cholera Vaccines Oral Live Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Cholera Vaccines Oral Live Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Cholera Vaccines Oral Live Market- Recent Developments

    • 6.1 Cholera Vaccines Oral Live Market News and Developments

    • 6.2 Cholera Vaccines Oral Live Market Deals Landscape

    7 Cholera Vaccines Oral Live Raw Materials and Cost Structure Analysis

    • 7.1 Cholera Vaccines Oral Live Key Raw Materials

    • 7.2 Cholera Vaccines Oral Live Price Trend of Key Raw Materials

    • 7.3 Cholera Vaccines Oral Live Key Suppliers of Raw Materials

    • 7.4 Cholera Vaccines Oral Live Market Concentration Rate of Raw Materials

    • 7.5 Cholera Vaccines Oral Live Cost Structure Analysis

      • 7.5.1 Cholera Vaccines Oral Live Raw Materials Analysis

      • 7.5.2 Cholera Vaccines Oral Live Labor Cost Analysis

      • 7.5.3 Cholera Vaccines Oral Live Manufacturing Expenses Analysis

    8 Global Cholera Vaccines Oral Live Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Cholera Vaccines Oral Live Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Cholera Vaccines Oral Live Export by Region (Top 10 Countries) (2017-2028)

    9 Global Cholera Vaccines Oral Live Market Outlook by Types and Applications to 2022

    • 9.1 Global Cholera Vaccines Oral Live Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Dukoral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Shanchol Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Vaxchora Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cholera Vaccines Oral Live Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Scientific Research Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Cholera Vaccines Oral Live Market Analysis and Outlook till 2022

    • 10.1 Global Cholera Vaccines Oral Live Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.2.2 Canada Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.2.3 Mexico Cholera Vaccines Oral Live Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.2 UK Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.3 Spain Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.4 Belgium Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.5 France Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.6 Italy Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.7 Denmark Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.8 Finland Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.9 Norway Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.10 Sweden Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.11 Poland Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.12 Russia Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.3.13 Turkey Cholera Vaccines Oral Live Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.4.2 Japan Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.4.3 India Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.4.4 South Korea Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.4.5 Pakistan Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.4.6 Bangladesh Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.4.7 Indonesia Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.4.8 Thailand Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.4.9 Singapore Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.4.10 Malaysia Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.4.11 Philippines Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.4.12 Vietnam Cholera Vaccines Oral Live Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.5.2 Colombia Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.5.3 Chile Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.5.4 Argentina Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.5.5 Venezuela Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.5.6 Peru Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.5.7 Puerto Rico Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.5.8 Ecuador Cholera Vaccines Oral Live Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.6.2 Kuwait Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.6.3 Oman Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.6.4 Qatar Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Cholera Vaccines Oral Live Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.7.2 South Africa Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.7.3 Egypt Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.7.4 Algeria Cholera Vaccines Oral Live Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Cholera Vaccines Oral Live Consumption (2017-2022)

      • 10.8.2 New Zealand Cholera Vaccines Oral Live Consumption (2017-2022)

    11 Global Cholera Vaccines Oral Live Competitive Analysis

    • 11.1 Shantha Biotechnics Limited

      • 11.1.1 Shantha Biotechnics Limited Company Details

      • 11.1.2 Shantha Biotechnics Limited Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Shantha Biotechnics Limited Cholera Vaccines Oral Live Main Business and Markets Served

      • 11.1.4 Shantha Biotechnics Limited Cholera Vaccines Oral Live Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Valneva

      • 11.2.1 Valneva Company Details

      • 11.2.2 Valneva Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Valneva Cholera Vaccines Oral Live Main Business and Markets Served

      • 11.2.4 Valneva Cholera Vaccines Oral Live Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Celldex Therapeutics

      • 11.3.1 Celldex Therapeutics Company Details

      • 11.3.2 Celldex Therapeutics Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Celldex Therapeutics Cholera Vaccines Oral Live Main Business and Markets Served

      • 11.3.4 Celldex Therapeutics Cholera Vaccines Oral Live Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merck

      • 11.4.1 Merck Company Details

      • 11.4.2 Merck Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merck Cholera Vaccines Oral Live Main Business and Markets Served

      • 11.4.4 Merck Cholera Vaccines Oral Live Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Ceva Asia

      • 11.5.1 Ceva Asia Company Details

      • 11.5.2 Ceva Asia Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Ceva Asia Cholera Vaccines Oral Live Main Business and Markets Served

      • 11.5.4 Ceva Asia Cholera Vaccines Oral Live Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 PaxVax

      • 11.6.1 PaxVax Company Details

      • 11.6.2 PaxVax Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 PaxVax Cholera Vaccines Oral Live Main Business and Markets Served

      • 11.6.4 PaxVax Cholera Vaccines Oral Live Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    12 Global Cholera Vaccines Oral Live Market Outlook by Types and Applications to 2028

    • 12.1 Global Cholera Vaccines Oral Live Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Dukoral Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Shanchol Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Vaxchora Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Cholera Vaccines Oral Live Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Cholera Vaccines Oral Live Market Analysis and Outlook to 2028

    • 13.1 Global Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.2.2 Canada Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.2 UK Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.3 Spain Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.5 France Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.6 Italy Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.8 Finland Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.9 Norway Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.11 Poland Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.12 Russia Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.4.2 Japan Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.4.3 India Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.5.3 Chile Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.5.6 Peru Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.6.3 Oman Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Cholera Vaccines Oral Live Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Cholera Vaccines Oral Live

    • Figure of Cholera Vaccines Oral Live Picture

    • Table Global Cholera Vaccines Oral Live Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Cholera Vaccines Oral Live Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Dukoral Consumption and Growth Rate (2017-2022)

    • Figure Global Shanchol Consumption and Growth Rate (2017-2022)

    • Figure Global Vaxchora Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Scientific Research Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Cholera Vaccines Oral Live Consumption by Country (2017-2022)

    • Table North America Cholera Vaccines Oral Live Consumption by Country (2017-2022)

    • Figure United States Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Canada Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Mexico Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Table Europe Cholera Vaccines Oral Live Consumption by Country (2017-2022)

    • Figure Germany Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure UK Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Spain Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Belgium Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure France Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Italy Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Denmark Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Finland Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Norway Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Sweden Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Poland Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Russia Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Turkey Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Table APAC Cholera Vaccines Oral Live Consumption by Country (2017-2022)

    • Figure China Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Japan Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure India Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Thailand Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Singapore Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Philippines Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Table South America Cholera Vaccines Oral Live Consumption by Country (2017-2022)

    • Figure Brazil Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Colombia Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Chile Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Argentina Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Peru Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Table GCC Cholera Vaccines Oral Live Consumption by Country (2017-2022)

    • Figure Bahrain Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Oman Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Qatar Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Table Africa Cholera Vaccines Oral Live Consumption by Country (2017-2022)

    • Figure Nigeria Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure South Africa Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Egypt Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure Algeria Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Table Oceania Cholera Vaccines Oral Live Consumption by Country (2017-2022)

    • Figure Australia Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Cholera Vaccines Oral Live Consumption and Growth Rate (2017-2022)

    • Table Shantha Biotechnics Limited Company Details

    • Table Shantha Biotechnics Limited Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shantha Biotechnics Limited Cholera Vaccines Oral Live Main Business and Markets Served

    • Table Shantha Biotechnics Limited Cholera Vaccines Oral Live Product Portfolio

    • Table Valneva Company Details

    • Table Valneva Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valneva Cholera Vaccines Oral Live Main Business and Markets Served

    • Table Valneva Cholera Vaccines Oral Live Product Portfolio

    • Table Celldex Therapeutics Company Details

    • Table Celldex Therapeutics Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celldex Therapeutics Cholera Vaccines Oral Live Main Business and Markets Served

    • Table Celldex Therapeutics Cholera Vaccines Oral Live Product Portfolio

    • Table Merck Company Details

    • Table Merck Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Cholera Vaccines Oral Live Main Business and Markets Served

    • Table Merck Cholera Vaccines Oral Live Product Portfolio

    • Table Ceva Asia Company Details

    • Table Ceva Asia Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ceva Asia Cholera Vaccines Oral Live Main Business and Markets Served

    • Table Ceva Asia Cholera Vaccines Oral Live Product Portfolio

    • Table PaxVax Company Details

    • Table PaxVax Cholera Vaccines Oral Live Sales, Price, Value and Gross Profit (2017-2022)

    • Table PaxVax Cholera Vaccines Oral Live Main Business and Markets Served

    • Table PaxVax Cholera Vaccines Oral Live Product Portfolio

    • Figure Global Dukoral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Shanchol Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaxchora Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cholera Vaccines Oral Live Consumption Forecast by Country (2022-2028)

    • Table North America Cholera Vaccines Oral Live Consumption Forecast by Country (2022-2028)

    • Figure United States Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cholera Vaccines Oral Live Consumption Forecast by Country (2022-2028)

    • Figure Germany Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Cholera Vaccines Oral Live Consumption Forecast by Country (2022-2028)

    • Figure China Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Cholera Vaccines Oral Live Consumption Forecast by Country (2022-2028)

    • Figure Brazil Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Cholera Vaccines Oral Live Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Cholera Vaccines Oral Live Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Cholera Vaccines Oral Live Consumption Forecast by Country (2022-2028)

    • Figure Australia Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Cholera Vaccines Oral Live Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US